Your browser doesn't support javascript.
loading
A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer.
Tabernero, Josep; Van Cutsem, Eric; Garralda, Elena; Tai, David; De Braud, Filippo; Geva, Ravit; van Bussel, Mark T J; Fiorella Dotti, Katia; Elez, Elena; de Miguel, María J; Litwiler, Kevin; Murphy, Danielle; Edwards, Michelle; Morris, Van Karlyle.
Afiliação
  • Tabernero J; Vall d'Hebron Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), UVic-UCC, IOB-Quiron, Barcelona, Spain.
  • Van Cutsem E; University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium.
  • Garralda E; START Madrid, Hospital Universitario HM Sanchinarro, Madrid, Spain.
  • Tai D; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • De Braud F; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Geva R; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
  • van Bussel MTJ; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Fiorella Dotti K; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Elez E; Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • de Miguel MJ; START Madrid, Hospital Universitario HM Sanchinarro, Madrid, Spain.
  • Litwiler K; Pfizer, Boulder, CO, USA.
  • Murphy D; Pfizer, La Jolla, CA, USA.
  • Edwards M; Pfizer, New York, NY, USA.
  • Morris VK; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Oncologist ; 28(3): 230-238, 2023 03 17.
Article em En | MEDLINE | ID: mdl-36811382

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Hipercalcemia Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Hipercalcemia Idioma: En Ano de publicação: 2023 Tipo de documento: Article